Larimar Therapeutics (LRMR) Return on Capital Employed Growth (3y) (2017 - 2025)
Larimar Therapeutics (LRMR) Return on Capital Employed Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | -13,875.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13,875.00 |
| Sep 30, 2025 | -7,339.00 |
| Jun 30, 2025 | -819.00 |
| Mar 31, 2025 | 690.00 |
| Dec 31, 2024 | 1,872.00 |
| Sep 30, 2024 | 4,042.00 |
| Jun 30, 2024 | 3,256.00 |
| Mar 31, 2024 | 8,704.00 |
| Dec 31, 2023 | -107,093.00 |
| Sep 30, 2023 | -955,987.00 |
| Jun 30, 2023 | 6,724.00 |
| Mar 31, 2023 | 5,429.00 |
| Dec 31, 2022 | 4,293.00 |
| Sep 30, 2022 | 938.00 |
| Jun 30, 2022 | -2,309.00 |
| Mar 31, 2022 | -1,410.00 |
| Dec 31, 2021 | -1,395.00 |
| Sep 30, 2021 | -1,211.00 |
| Jun 30, 2021 | 1,241.00 |
| Mar 31, 2021 | -5,846.00 |